|Videos|October 22, 2013
Regulation of Compounding Pharmacies
David G. Miller, RPh, discusses whether and how regulation of compounding pharmacies needs to change.
Advertisement
In this video, shot at the National Community Pharmacists Association 115th Annual Convention in Orlando, David G. Miller, RPh, executive vice president and CEO of the International Academy of Compounding Pharmacists, discusses whether and how regulation of compounding pharmacies needs to change in the wake of the meningitis outbreak caused by tainted steroids produced by the New England Compounding Center.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
RSV Hospitalization Associated With Persistent Symptoms and Reduced Quality of Life in Adults
2
December 2025 Product Updates
3
FLEX Study Data Highlight Role of Genomic Testing in Guiding Early-Stage Breast Cancer Treatment
4
Study Links Specific Air Pollution Components to Increased Depression Risk in Older Adults
5